Aspen Neuroscience
Latest round
- Series C
Last raised
- Nov 2025
Total raised
- $339M
Investors
- 21
About Aspen Neuroscience
, based in the US, specializes in innovative cell therapy solutions aimed at treating neurological conditions, particularly Parkinson's disease. Founded in 2018 and headquartered in San Diego, California, Aspen Neuroscience develops advanced therapies utilizing autologous induced pluripotent stem cells (iPSCs). The firm has attracted attention for its product ANPD001, targeting the restoration of dopamine neurons in Parkinson’s patients. In November 2025, Aspen Neuroscience, Inc., Prebys Foundation, Cormorant Asset Management and BAM Elevate. Aspen Neuroscience specializes in personalized cell therapy, offering the world's first autologous iPSC-derived neuron replacement therapy designed for Parkinson's disease. The therapy, ANPD001, addresses the severe loss of dopamine neurons in affected patients, which can exceed 50% before diagnosis. It involves reprogramming a small sample of the patient's skin cells into unique iPSCs, with the aim of restoring neuronal function and enhancing patient quality of life.S. market, targeting individuals with Parkinson's and collaborating healthcare institutions. Aspen Neuroscience is in the investigational stage with ANPD001, which is not yet approved for commercial sale. Therefore, the company does not generate revenue from direct sales. Its business model relies on investments and partnerships within clinical trials, focusing on research and development costs. Future revenue will depend on the successful commercialization of ANPD001 following FDA approval, at which point the company will establish pricing strategies for healthcare facilities and potential pharmaceutical distributors. In November 2025, Aspen Neuroscience, Inc., Prebys Foundation, Cormorant Asset Management and BAM Elevate.
Who invested in Aspen Neuroscience
21 investors across 4 rounds
See all investors in Aspen Neuroscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Aspen Neuroscience
Who invested in Aspen Neuroscience?
Aspen Neuroscience has 21 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aspen Neuroscience raised?
Aspen Neuroscience has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Aspen Neuroscience last raise money?
Aspen Neuroscience's most recent round on record is a Series C, in Nov 2025.
What does Aspen Neuroscience do?
, based in the US, specializes in innovative cell therapy solutions aimed at treating neurological conditions, particularly Parkinson's disease.
Where is Aspen Neuroscience headquartered?
Aspen Neuroscience is headquartered in San Diego, US.
Which VCs invest in companies like Aspen Neuroscience?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aspen Neuroscience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Aspen Neuroscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.